KR100631857B1 - 감마아미노부틸산(gaba) 고생산성 균주인락토바실러스 브레비스 오피케이-3 - Google Patents
감마아미노부틸산(gaba) 고생산성 균주인락토바실러스 브레비스 오피케이-3 Download PDFInfo
- Publication number
- KR100631857B1 KR100631857B1 KR1020040055286A KR20040055286A KR100631857B1 KR 100631857 B1 KR100631857 B1 KR 100631857B1 KR 1020040055286 A KR1020040055286 A KR 1020040055286A KR 20040055286 A KR20040055286 A KR 20040055286A KR 100631857 B1 KR100631857 B1 KR 100631857B1
- Authority
- KR
- South Korea
- Prior art keywords
- gaba
- lactobacillus brevis
- strain
- gamma
- present
- Prior art date
Links
- 240000001929 Lactobacillus brevis Species 0.000 title claims abstract description 23
- 235000013957 Lactobacillus brevis Nutrition 0.000 title claims abstract description 23
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 title abstract description 100
- 229960003692 gamma aminobutyric acid Drugs 0.000 title abstract description 52
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 title abstract description 50
- 238000004519 manufacturing process Methods 0.000 title abstract description 16
- -1 Aminobutyl Chemical group 0.000 claims abstract description 13
- 239000002253 acid Substances 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims description 15
- 235000013305 food Nutrition 0.000 claims description 9
- 238000012258 culturing Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000003674 animal food additive Substances 0.000 abstract description 4
- 235000013373 food additive Nutrition 0.000 abstract description 4
- 239000002778 food additive Substances 0.000 abstract description 4
- 238000012360 testing method Methods 0.000 abstract description 3
- 230000001476 alcoholic effect Effects 0.000 abstract description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 40
- 239000004310 lactic acid Substances 0.000 description 20
- 235000014655 lactic acid Nutrition 0.000 description 20
- 241000894006 Bacteria Species 0.000 description 17
- 235000021109 kimchi Nutrition 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 241000186660 Lactobacillus Species 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 229960001031 glucose Drugs 0.000 description 4
- 229940039696 lactobacillus Drugs 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 108020004465 16S ribosomal RNA Proteins 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 102000016938 Catalase Human genes 0.000 description 3
- 108010053835 Catalase Proteins 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000010794 food waste Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 235000013618 yogurt Nutrition 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 238000003794 Gram staining Methods 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical group CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 238000013418 fluorescence derivatisation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 241000193798 Aerococcus Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000202221 Weissella Species 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- JDZJVWAHZYIHFA-UHFFFAOYSA-N [Br].C1(=CC=CC=C1)O Chemical compound [Br].C1(=CC=CC=C1)O JDZJVWAHZYIHFA-UHFFFAOYSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical compound OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- RQVGAIADHNPSME-UHFFFAOYSA-N azinphos-ethyl Chemical compound C1=CC=C2C(=O)N(CSP(=S)(OCC)OCC)N=NC2=C1 RQVGAIADHNPSME-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000007444 cell Immobilization Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000012595 freezing medium Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- HOVAGTYPODGVJG-ZFYZTMLRSA-N methyl alpha-D-glucopyranoside Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-ZFYZTMLRSA-N 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003791 organic solvent mixture Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
선발균주 | |
세포의 그람염색 | 그람양성균주 |
형태 | 간균 |
포자생성 | - |
포도당 배지에서의 가스생성능 | CO2 생성 |
카탈라아제 생성능 | + |
15℃에서 생장능력 | + |
45℃에서 생장능력 | - |
미생물 크기(㎛) | 1.0-1.5㎛ |
탄수화물 | 선발균주 | |
1 | 말토오즈 | + |
2 | D-(+)-글루코오즈 | + |
3 | 람노오즈 | - |
4 | 덱스트로오즈 | + |
5 | D-락토오즈 | + |
6 | D-(+)-트레할로오즈 | + |
7 | D-(+)-만노오즈 | + |
8 | 수크로오즈 | + |
9 | D-솔비톨 | - |
10 | 이뉼린 | - |
11 | D-만니톨 | + |
12 | D-(+)-자일로오즈 | - |
13 | D-(-)-아라비노오즈 | - |
14 | D-(+)-셀로비오즈 | + |
15 | 메틸α-D-글루코피라노사이드 | ± |
16 | L-아르기닌 | - |
17 | D-(+)-라피노오즈 | + |
균주 | GABA함량(nmol/㎖) |
Lactobacillus OPK-3 | 2503.08 |
Lactobacillus plantarum kctc3103 | 30.09 |
Lactobacillus brevis kctc 41028 | 2.09 |
Lactobacillus brevis kctc 41029 | 5.15 |
Claims (4)
- 감마아미노부틸산(GABA) 고생산성 균주인 락토바실러스 브레비스 오피케이-3(KFCC-11330)
- 락토바실러스 브레비스 오피케이-3(KFCC-11330) 균을 배양하여 배양물로부터 감마아미노부틸산(GABA)을 제조하는 방법
- 감마아미노부틸산(GABA) 고생산성 균주인 락토바실러스 브레비스 오피케이-3(KFCC-11330)를 함유하는 식품조성물
- 감마아미노부틸산(GABA) 고생산성 균주인 락토바실러스 브레비스 오피케이-3(KFCC-11330)를 함유하는 사료조성물
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040055286A KR100631857B1 (ko) | 2004-07-15 | 2004-07-15 | 감마아미노부틸산(gaba) 고생산성 균주인락토바실러스 브레비스 오피케이-3 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040055286A KR100631857B1 (ko) | 2004-07-15 | 2004-07-15 | 감마아미노부틸산(gaba) 고생산성 균주인락토바실러스 브레비스 오피케이-3 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20060006342A KR20060006342A (ko) | 2006-01-19 |
KR100631857B1 true KR100631857B1 (ko) | 2006-10-09 |
Family
ID=37118047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040055286A KR100631857B1 (ko) | 2004-07-15 | 2004-07-15 | 감마아미노부틸산(gaba) 고생산성 균주인락토바실러스 브레비스 오피케이-3 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100631857B1 (ko) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100910657B1 (ko) | 2007-02-23 | 2009-08-05 | 박현진 | 신규한 락토바실러스 브츠네리 및 이의 용도 |
WO2014208848A1 (ko) * | 2013-06-24 | 2014-12-31 | 목포대학교 산학협력단 | 감마아미노부틸산 고생산성 락토바실러스 브레비스 및 그의 용도 |
KR101549633B1 (ko) | 2013-02-06 | 2015-09-03 | 전남대학교산학협력단 | 신규한 락토바실러스 브레비스 k203 균주 및 이를 이용한 감마 아미노뷰티르산의 고효율 생산방법 |
KR101885878B1 (ko) | 2017-10-30 | 2018-08-07 | (주)셀텍 | 대장균 형질전환체를 이용한 감마아미노부틸산의 생산방법 및 감마아미노부틸산 함유 사료첨가제의 제조방법 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100753864B1 (ko) * | 2005-11-18 | 2007-08-31 | 우석대학교 산학협력단 | 감마아미노부티르산을 다량 생산하는 균주, 이를 포함하는발효 출발 물질 조성물, 및 이를 이용하여 제조된 발효식품 및 기능성 식품 |
KR101305800B1 (ko) * | 2009-11-30 | 2013-09-06 | 한남대학교 산학협력단 | 글루타메이트 디카르복실라아제 활성을 갖는 신규 락토바실러스 균주 및 이를 이용한 아미노부틸산 제조방법 |
KR101597781B1 (ko) * | 2013-06-03 | 2016-02-25 | 주식회사 씨티씨바이오 | 락토바실러스 브레비스 g-101 및 이의 용도 |
BE1026084B1 (nl) | 2018-03-07 | 2019-10-10 | Nutrition Sciences N.V. | Probiotische samenstelling voor gebruik in een voederadditief |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000210075A (ja) | 1999-01-21 | 2000-08-02 | Taiyo Corp | γ―アミノ酪酸高生産能を有する乳酸菌、及びその乳酸菌を使用したγ―アミノ酪酸高含有発酵食品とその製造法。 |
-
2004
- 2004-07-15 KR KR1020040055286A patent/KR100631857B1/ko active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000210075A (ja) | 1999-01-21 | 2000-08-02 | Taiyo Corp | γ―アミノ酪酸高生産能を有する乳酸菌、及びその乳酸菌を使用したγ―アミノ酪酸高含有発酵食品とその製造法。 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100910657B1 (ko) | 2007-02-23 | 2009-08-05 | 박현진 | 신규한 락토바실러스 브츠네리 및 이의 용도 |
KR101549633B1 (ko) | 2013-02-06 | 2015-09-03 | 전남대학교산학협력단 | 신규한 락토바실러스 브레비스 k203 균주 및 이를 이용한 감마 아미노뷰티르산의 고효율 생산방법 |
WO2014208848A1 (ko) * | 2013-06-24 | 2014-12-31 | 목포대학교 산학협력단 | 감마아미노부틸산 고생산성 락토바실러스 브레비스 및 그의 용도 |
KR101885878B1 (ko) | 2017-10-30 | 2018-08-07 | (주)셀텍 | 대장균 형질전환체를 이용한 감마아미노부틸산의 생산방법 및 감마아미노부틸산 함유 사료첨가제의 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
KR20060006342A (ko) | 2006-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI241912B (en) | Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol | |
TWI739078B (zh) | 脂肪累積抑制用組成物 | |
KR20060016048A (ko) | 체지방 저하 기능성 락토바실러스 람노서스와 이를 함유한식품 | |
WO2019112217A1 (ko) | 글리세롤로부터 루테린을 고생산하는 락토바실러스 루테리 oh0335 균주 및 이의 용도 | |
WO2014208848A1 (ko) | 감마아미노부틸산 고생산성 락토바실러스 브레비스 및 그의 용도 | |
KR101349692B1 (ko) | 알코올 내성 유산균 페디오코커스 애시디락티시 및 그 응용 | |
KR100734975B1 (ko) | 1-데옥시노지리마이신을 생산하는 바실러스 서브틸리스s10 균주 및 이를 유효성분으로 함유하는 조성물 | |
KR100631857B1 (ko) | 감마아미노부틸산(gaba) 고생산성 균주인락토바실러스 브레비스 오피케이-3 | |
KR101451810B1 (ko) | 감마-아미노부티르산 생산능이 우수한 신규한 락토바실러스 플랜타룸 k255 균주 | |
KR102130646B1 (ko) | 신규한 락토바실러스 살리바리우스 및 이를 유효성분으로 포함하는 양식 어류 및 갑각류용 사료첨가제 | |
KR20080100068A (ko) | 락토바실러스 부크네리 opυ-2 균주 및 이를 함유하는발효유 | |
KR100661824B1 (ko) | 락토바실러스 브레비스 opy-1 균주 및 이 균주를함유한 발효유 | |
KR100609779B1 (ko) | 알코올과 아세트알데하이드를 분해하는 젖산균 | |
KR100455832B1 (ko) | 김치에서 분리한 내산성 및 내담즙산성이 우수한 신규락토바실러스 플랜타륨 및 이를 함유하는 제품 | |
KR101655778B1 (ko) | 락토바실러스 플란타룸 k46 및 이를 포함하는 조성물 | |
KR100661823B1 (ko) | Gaba 고생산능을 가지는 신규한 락토코커스 유산균,이를 이용한 발효스타터 및 gaba의 생산방법 | |
KR100442205B1 (ko) | β- 글루코시다제를 생산하는 비피도박테리움 락티스 및이를 이용하여 이소플라본을 이소플라본 비배당체로전환하는 방법 | |
KR101470995B1 (ko) | 프로피온산 생산능을 갖는 미생물 및 그를 포함하는 조사료 조성물 | |
KR101341649B1 (ko) | 내산성 및 내담즙성이 우수한 식물 유래 유산균 및 그 용도 | |
CN114763519A (zh) | 食淀粉乳杆菌lam1345分离株及其用途 | |
Anthony et al. | Evaluation of Mucuna beans flour fermented with Lactobacillus plantarum as a probiotic food | |
KR101063624B1 (ko) | 오미자 발효물, 그 발효방법 및 상기 발효물을 포함하는 식품 조성물 | |
CN112538439B (zh) | 一种植物乳杆菌及其制备植物性凝态酸奶、改善肠道菌相的用途 | |
KR101804778B1 (ko) | 기능성 희소당 알룰로스의 생산능을 가지는 락토바실러스 플란타룸 hy7716 및 이를 유효성분으로 함유하는 제품 | |
KR20150088588A (ko) | 신규한 감마아미노부티르산 고생산성 균주 락토바실러스 브레비스 cfm11 및 이의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120917 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20130912 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140925 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20151027 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160825 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180731 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190906 Year of fee payment: 14 |
|
R401 | Registration of restoration |